Bacteria Therapy for Eczema Shows Promise in NIH Study

A scientist demonstrates application of the experimental therapy to the inner elbow. For demonstration purposes, the bacteria solution has been replaced with purple dye. 

Topical treatment with live Roseomonas mucosa bacteria was safe for adults and children with eczema and was associated with reduced disease severity, according to initial findings from an ongoing NIAID clinical trial. By applying bacteria from a healthy source to the skin of people with eczema, researchers aim to alter the skin microbiome—the community of bacteria and other microbes living on the skin—to relieve disease symptoms. Results from this early stage study will provide the foundation for larger trials to evaluate the efficacy of this novel investigational therapy.

Read more and watch a short video describing the findings.